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Objective. This study was undertaken to gain an insight into the relationship between Helicobacter pylori (H. pylori) infection,
Barrett’s esophagus and reﬂux esophagitis in an area of exceptionally low prevalence of H. pylori infection. Methods.At o t a lo f
1895 consecutive upper endoscopies performed between January 2005 and July 2007 were reviewed. 120 cases of columnar-lined
esophagus and endoscopic esophagitis were evaluated. H. pylori infection was determined using the urease test and/or histology.
Results. The rate of endoscopic esophagitis was 5.49% (80 Malays, 24 non-Malays) while histological reﬂux esophagitis was found
in 3.75% (56 Malays, 15 non-Malays). Barrett’s esophagus was present in 0.79% (11 Malays, 4 non-Malays). H. pylori infection
was present in 8/120 or 6.67% subjects. Conclusion. The low rate of Barrett’s esophagus in this population does not support the
hypothesis that the absence of H. pylori infection is more than a minor risk factor for Barrett’s esophagus.
1.Introduction
Reﬂux esophagitis is thought to be uncommon among
Asians,butrecentstudieshaveshownthaterosiveesophagitis
is more common than what was originally thought [1, 2].
Similarly, Barrett’s esophagus, a precursor of esophagus
adenocarcinoma, is thought to have a low prevalence among
Asians. There are two reports from Peninsular Malaysia
showingdiﬀerentratesofBarrett’sesophagusintwodiﬀerent
regions. Rajendra et al. [3] reported a 6% prevalence rate of
Barrett’s esophagus in the northwestern part of Peninsular
Malaysia while Rosaida and Goh [4] in the Klang Valley
of central Peninsular Malaysia reported a rate of 2%. The
diﬀerence in rates may be related to diﬀerences in the
ethnic composition of the population in these regions. The
predominantly Malay population of northeastern Peninsular
Malaysia has a naturally low Helicobacter pylori (H. pylori)
prevalence rate of 4%-5%, a rate that is among the lowest
reported in the world [5–7]. The H. pylori seroprevalence
was also studied in the Aboriginal (Orang Asli) community
from this region, and the prevalence rate was only 19%
[8]. In a recent study, patients underwent upper endoscopy
in northeastern Peninsular Malaysia; the rate of chronic
atrophic gastritis was found to be 42%, and H. pylori
infection was present in only 11% of the study sample [9].
The aim of this study was to determine the rate of Barrett’s
esophagus and histological oesophagitis in an endoscopy-
based sample of this unique population with a view to
gaining an insight into the relationship between H. pylori
infectionand Barrett’s esophagus. This isespeciallypertinent
in the light of recent suggestions of an inverse relationship
between H. pylori infection, gastroesophageal reﬂux disease
(GERD), Barrett’s and esophageal adenocarcinoma.
2. Patients andMethods
A total of 1895 consecutive patients who underwent
endoscopy for upper gastrointestinal symptoms between
2005 and 2007 at Hospital Universiti Sains Malaysia (USM)2 ISRN Gastroenterology
Table 1: Characteristics of study sample in relation to presence of esophagitis and Barrett’s esophagus.
Endoscopic esophagitis Endoscopic Barrett’s esophagus
Number of cases (n) 104 16
Age (Mean ± SD, years) 53.6 ±1.56 1 .4 ±3.2
Gender
Male (n)5 9 9
Female (n)4 5 7
Biopsy-conﬁrmed cases (n)
(1) Erosive esophagitis 65 6
(2) Barrett’s esophagus without concomitant esophagitis 1 1
(3) Barrett’s esophagus with concomitant esophagitis 7 6
Normal histology 31 3
Prevalence (%) 3.74 0.78
Helicobacter pylori (n)6 2
SD: standard deviation.
Table 2: Ethnic distribution of subjects with reﬂux esophagitis and Barrett’s esophagus.
Malay non-Malay
Endoscopically diagnosed 80 24
(1) Erosive oesophagitis (n)4 61 4
LA grade A 13 4
LA grade B 14 4
LA grade C 7 2
LA grade D
(2) Barrett’s (n)1 4 2
Biopsy-conﬁrmed Barrett’s (n)1 1 4 ∗
Helicobacter pylori positive 6 2#
LA:LosAngelesClassiﬁcationforerosiveoesophagitis;N:totalnumberofupperendoscopiesscreenedbetween2005to2007. ∗3Chinese,1Indian. #1Chinese,
1 Indian.
were recruited into the study. The upper gastrointestinal
symptoms included dyspepsia (both typical and atypical),
chest discomfort, epigastric pain, heartburn, acid regurgi-
tation, dysphagia, nausea, and/or vomiting. This hospital is
a teaching and tertiary referral centre serving Northeastern
Peninsular Malaysia. All upper endoscopies (model GIF-
140 and GIF-160; Olympus Medical Systems, Tokyo, Japan)
during this period were performed by two experienced
endoscopists (Y. Y. Lee, S. H. S. Abd Aziz) who ini-
tially agreed on a consensus of endoscopic assessment to
reduce ﬁnding variations. If needed, patients were sedated
accordingly. Patients with esophagitis visible on endoscopy
and/or columnar-lined esophagus were biopsied. Patients
aged from 18 years old and elder were included, and those
with esophageal carcinoma, history of upper gastrointestinal
surgery, esophageal varices, or repeated endoscopy were
excluded.
Endoscopic esophagitis was classiﬁed according to Los
Angeles(LA)classiﬁcation(GradeAtoD)asdescribedprevi-
ously [10]. Barrett’s esophagus was identiﬁed as an extension
ofcolumnarepitheliumabovethegastroesophagealjunction.
It was standard practice for all patients with esophagitis
or suspected Barrett’s esophagus to be biopsied at multiple
levels at the squamocolumnar junction. H. pylori infection
was routinely determined during endoscopy using the rapid
urease test or CLO test (Ballard Medical Products, Utah,
USA) and/or histology with or without Werthein stain from
two tissue biopsies taken over the antrum and/or the body.
Reﬂux esophagitis was deﬁned histologically by the
presenceofbasalcellthickening,elongationofpapillaeofthe
epithelium, dilated vessels in the papillae of lamina propria,
and distended pale squamous cells. The severity of reﬂux
esophagitiswasrecordedasmild,moderate,andseverebased
on the presence of lymphoplasma cells inﬁltration in the
tissue sample, and a visual grading of severity was given
by the pathologist based on the volume of cell inﬁltration
[11]. Barrett’s esophagus was conﬁrmed histologically by
the presence of intestinal metaplasia epithelium within
the columnar-lined esophagus which contains goblet cells
and stains positively with Alcian blue [12]. Dysplasia was
identiﬁed by the presence of deﬁnite cytologic and architec-
tural abnormalities in the neoplastic epithelium. Cases were
excluded if the diagnosis of dysplasia was confounded by the
presence of marked inﬂammation [13].
Statistical analysis was performed using SPSS software
version 12.0.1 (SPSS Inc, Chicago, Ill, USA). Chi-square test
or Fischer’s exact test was used for categorical variables and
independentt testfornumericalvariableswhereappropriate.
A P value of less than 0.05 was considered statistically
signiﬁcant.ISRN Gastroenterology 3
Table 3: Reported prevalence of esophagitis and Barrett’s esophagus in diﬀerent populations based on endoscopy study.
Region Sample size (n) Prevalence n (%) of
Esophagitis Barrett’s
Rajendra et al. [3] Northwestern Peninsular Malaysia 1985 121 (6.1) 123 (6.2)
Rosaida and Goh [4] Klang Valley, Peninsular Malaysia 1000 134 (13.4) 20 (2.0)
Current study Northeastern Peninsular Malaysia 1895 104 (5.49) 15 (0.79)
Xiong et al. [14] Guangzhou, China 2022 68 (3.4) 21 (1.0)
Wong et al. [15] Hong Kong 16606 631 (3.8) 10 (0.06)
Yeh et al. [16] Taiwan 464 66 (14.5) 9 (2.0)
Yilmaz et al. [17] Turkey 18,766 2402 (12.8) 280 (1.5)
Ronkainen et al. [18] Sweden 1000 155 (15.5) 16 (1.6)
Rex et al. [19] USA 961 155 (16.1) 65 (6.8)
3. Results
The rate of esophagitis seen endoscopically was 5.49%
(104/1895) of which 71 patients were later conﬁrmed histo-
logically (Table 1). More males had endoscopic esophagitis
than females, but it was not statistically signiﬁcant (P =
0.97). Table 2 showed most patients had mild erosive
esophagitis. H. pylori infection was present in six patients
(6/104 or 5.77%) with endoscopic esophagitis and in two
patients with columnar lined oesophagus (2/16 or 12.50%).
The prevalence of Barrett’s esophagus conﬁrmed histolog-
ically was 0.78% (15/1895), while 0.84% (16/1895) had
columnar lined esophagus. However, only 43.75% (7/16)
of the patients suspected to have Barrett’s esophagus on
endoscopyfulﬁlledthehistologicalcriteriaofBarrett’sesoph-
agus (Table 1). Of the patients with endoscopic esophagitis,
7.69% (8/104) had histologically conﬁrmed Barrett’s esoph-
agus. In terms of ethnicity, non-Malays constituted 23.08%
(24/104) of patients with endoscopic esophagitis and 26.67%
(4/15) of patients with histologically conﬁrmed Barrett’s
esophagus (Table 2). Compared to the demographics of the
area and the ethnic distribution of all patients attending the
hospital during study period, non-Malays were overrepre-
sented among patients with reﬂux esophagitis and Barrett’s
esophagus. There was only one case of low-grade dysplasia
seen,andthepatienthadbackgroundhistoryofscleroderma.
Normal histology was reported in 34 cases of which 31 cases
were normal in erosive esophagitis seen endoscopically, and
3 cases were normal in suspected Barrett’s esophagus.
4. Discussion
It is acknowledged at the outset that any prevalence
study based on endoscopy is subject to selection bias.
Observer variation among endoscopists in the recognition
of esophagitis and Barrett’s esophagus constitutes another
limitation. Notwithstanding comparison with the data of
other endoscoped series does permit useful inferences.
The 5.49% prevalence rate of endoscopic esophagitis in
this study is generally lower than that reported in most other
endoscopy-based studies especially those from the Western
world (Table 3). In concordance with this observation, the
prevalence of Barrett’s esophagus is also low at 0.79%.
This is perhaps not surprising as Barrett’s esophagus is
considered to be a consequence of long-standing gastroe-
sophageal reﬂux disease. The diﬀerences in the prevalence
rates of esophagitis and Barrett’s esophagus reported in the
other two studies from Malaysia may relate to diﬀerences
in ethnic composition and socioeconomic demographics.
Northeastern Peninsular Malaysia has a larger proportion of
ethnic Malays (90%) than Northwestern (51.4%) or Central
(50%) Peninsular Malaysia. Rajendra et al. showed that
Indiansaremorepredisposedtogastroesophagealreﬂuxthan
Chinese or Malays demonstrating the potential role of ethnic
diﬀerences [3]. This is supported by an observation by the
same author of a predominance of human leucocyte antigen
(HLA)B7subtypeamongIndianswithBarrett’s[20].Indeed
even in our study non-Malays were overrepresented among
patients with reﬂux esophagitis and Barrett’s esophagus.
There has been a suggestion that H. pylori infection
rate is inversely related to the prevalence of GERD, Barrett’s
esophagus, and esophageal adenocarcinoma [21–23]. The
low rate of esophagitis and Barrett’s esophagus observed in
this study despite the fact that H. pylori is almost absent does
not support the notion that the absence of H. pylori infection
plays more than a minor role as a risk factor for Barrett’s
esophagus and reﬂux esophagitis. Other factors relating to
race, life style, and obesity are likely to be more important
than H. pylori. The fact that non-Malays in this study were
more likely to have esophagitis and Barrett’s esophagus
despite their well-documented higher prevalence of H. pylori
infection also argues against the decline of H. pylori being
an important factor in the etiopathogenesis of reﬂux disease.
Indeed in northeastern region of Peninsular Malaysia, the
age-standardised incidence of oesophageal adenocarcinoma
a sequelae of Barrett’s was found to be only 0.72/100,000
among the Malays [24]. Although progression from Barrett’s
to dysplasia is slow and rare (30% low-grade dysplasia and
5% high-grade dysplasia in six years) [25], it is notable that
onlyonecaseofdysplasiawasdetectedinthisstudy,andeven
that was in a patient with scleroderma, a condition known to
predispose to reﬂux esophagitis.
In conclusion, the low rate of Barrett’s esophagus in
this series from an area with an exceptionally low H. pylori
prevalence does not support the hypothesis that the absence
of H. pylori infection is more than a minor risk factor for4 ISRN Gastroenterology
Barrett’s esophagus. This is corroborated by the observation
that Non-malay subjects who have a higher prevalence of H.
pylori were more likely to have Barrett’s than the Malays.
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